2 great FTSE 100 stocks to own heading into a recession

Jabran Khan identifies two FTSE 100 stocks he feels are recession-proof and details their defensive capabilities.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Young brown woman delighted with what she sees on her screen

Image source: Getty Images

Many believe that a recession could be on the cards. With that in mind, I am on the lookout for the best FTSE 100 stocks for my holdings.

I have identified two I believe could be great picks. Let’s take a closer look at them.

Healthcare

My first pick is GlaxoSmithKline (LSE:GSK). It is one of the world’s biggest healthcare businesses developing and selling medicines and vaccines with a global footprint.

Healthcare stocks are often seen as recession-proof due to their defensive and essential nature. No matter the state of the economy, people need healthcare and medicines. Furthermore, the pandemic shone a new light on the importance of health and well-being in the past couple of years.

So what’s happening with GlaxoSmithKline shares currently? They’re trading for 1,786p, as I write. At this time last year, the shares were trading for 1,419p, which is a 25% increase over a 12-month period.

Although arguably recession-proof, Glaxo stock does have risks. Current macroeconomic headwinds such as the rising cost of materials and the supply chain crisis could negatively impact operations, performance and returns. These issues are affecting many FTSE 100 stocks, however

As well as GlaxoSmithKline’s defensive capabilities, it has a good track record of performance in recent years. I do understand that past performance is not a guarantee of the future, however. Positive performance and profits leads to investor returns in the form of dividends that could boost my passive income stream. Glaxo’s current dividend yield is 4.3%, higher than the FTSE 100 average of 3%-4%.

I would add GlaxoSmithKline shares to my holdings heading into a recession. Its profile, presence, performance record, as well as the passive income opportunity are too good to miss. It also has an excellent pipeline of drugs, which should support future growth.

Utilities

My next pick is National Grid (LSE:NG). It is the UK’s electricity system operator providing the population with power. In addition to this, in the US it powers 20m customers across Massachusetts, New York and Rhode Island.

Like healthcare, utilities are also often seen as defensive stocks in times of economic uncertainty. Power is one of the modern-day essentials for our homes and businesses after all.

So what’s happening with the National Grid share price currently? Well, as I write, they are trading for 1,080p. At this time last year, the stock was trading for 920p, which is a 17% increase over a 12-month period.

National Grid shares have risks, too. I did notice that it has a significant amount of debt on its balance sheet. Due to rising interest rates, this debt could become costlier to service. In turn, this could affect investor returns and sentiment.

The firm also has a good record of performance. This performance underpins a healthy dividend yield of close to 5%. Utility stocks are often seen as passive income safe-havens. It is worth noting, though, dividends can be cancelled at the discretion of the business at any time. This tends to happen more so during difficult economic periods or extreme events such as a pandemic.

I would happily add National Grid shares to my holdings, and view them as a defensive option for my portfolio for any impending recession.

Jabran Khan has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle aged businesswoman using laptop while working from home
Investing Articles

Is Legal & General a top bargain after its 8% share price drop?

Looking for brilliant dividend shares to buy on the cheap? Royston Wild takes a look at Legal & General following…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Up 19% in a day, is there more to come from the surging Diploma share price?

Diploma’s share price is storming higher. But does the stock offer safety in an uncertain market, or is buying at…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

How much do you need in a Stocks and Shares ISA to target £2,000 a month of passive income?

With a bit of maths, our writer illustrates how an investor could shrink their initial ISA investment while supersizing dividend…

Read more »

Number three written on white chat bubble on blue background
Investing Articles

The FTSE 100’s full of value shares at the moment. Here are 3 to consider

Recent events have taken their toll on the share prices of some of the UK’s biggest companies. But it also…

Read more »

Investing Articles

Should I buy beaten-down UK growth stocks today or conserve my cash for even bigger bargains?

Harvey Jones says the FTSE 100 is packed with cut-price growth stocks after recent volatility. Should investors buy now or…

Read more »

Number 5 foil balloon and gold confetti on black.
Investing Articles

£5,000 invested in Fresnillo shares 5 weeks ago is now worth…

Fresnillo shares have pulled back sharply from recent highs in the FTSE 100. Is this a chance to consider buying…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Down 15%, are Lloyds shares simply too cheap to miss now?

Have the wheels come off the long-term growth story for Lloyds Bank shares, or are they dipping into bargain territory…

Read more »

Business manager working at a pub doing the accountancy and some paperwork using a laptop computer
Investing Articles

Are investors taking a massive gamble by chasing the BP share price higher?

Investors who thought the BP share price would continue to rocket as the Iran war intensifies may have been surprised…

Read more »